PRELUDE THERAPEUTICS INCORPORATED - COMMON STOCK
0.7643
07-May-25 16:45:00
15 minutes delayed
Stocks
-0.0317
-3.98%
Today's range
0.7522 - 0.8170
ISIN
N/A
Source
NASDAQ
-
Prelude Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
09 Aug 2022 08:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces First Quarter 2022 Financial Results and Operations Update
10 May 2022 08:00:02 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Reports Full Year 2021 Financial Results
16 Mar 2022 07:30:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics to Participate at the Barclays 2022 Global Healthcare Conference
11 Mar 2022 08:00:00 By Nasdaq GlobeNewswire
-
09 Mar 2022 08:05:00 By Nasdaq GlobeNewswire
-
Jane Huang, M.D., Joins Prelude Therapeutics as President and Chief Medical Officer
09 Mar 2022 08:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference
11 Feb 2022 07:00:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference
04 Jan 2022 07:00:02 By Nasdaq GlobeNewswire
-
Prelude Therapeutics to Participate at the 4th Annual Evercore ISI HealthCONx Conference
23 Nov 2021 07:00:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update
12 Nov 2021 08:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor
08 Nov 2021 09:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences
02 Sep 2021 07:00:02 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update
12 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Appointment of Martin Babler to its Board of Directors
19 Jul 2021 07:00:01 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences
02 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update
11 May 2021 07:30:00 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Presentation at BofA Securities 2021 Virtual Health Care Conference
05 May 2021 07:00:01 By Nasdaq GlobeNewswire
-
16 Mar 2021 08:00:02 By Nasdaq GlobeNewswire
-
Prelude Therapeutics Announces Participation at Three Upcoming Virtual Investor Conferences
03 Mar 2021 07:00:00 By Nasdaq GlobeNewswire